Steward Partners Investment Advisory’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,000
| Closed | -$1K | – | 3284 |
|
|
2021
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 3098 |
|
|
2021
Q2 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 6886 |
|
|
2021
Q1 | $4.46K | Hold |
1,000
| – | – | ﹤0.01% | 3036 |
|
|
2020
Q4 | $4K | Buy |
+1,000
| New | +$4K | ﹤0.01% | 2579 |
|
|
2020
Q3 | – | Sell |
-200
| Closed | -$1K | – | 2822 |
|
|
2020
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 2596 |
|
|
2020
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 2648 |
|
|
2019
Q4 | $0 | Hold |
200
| – | – | ﹤0.01% | 2705 |
|
|
2019
Q3 | $0 | Hold |
200
| – | – | ﹤0.01% | 2730 |
|
|
2019
Q2 | $0 | Buy |
+200
| New | – | ﹤0.01% | 2673 |
|
|
2018
Q4 | – | Sell |
-200
| Closed | -$1K | – | 1772 |
|
|
2018
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 2514 |
|
|
2018
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 2374 |
|
|
2018
Q1 | $1K | Buy |
+200
| New | +$1K | ﹤0.01% | 2158 |
|